COMP <GO>
MENS vs DERM // EV/EBITDA & P/E VALUATION
Jyong Biotech Ltd. (NASDAQ) VS. Journey Medical Corporation (NASDAQ) • 15-METRIC TALLY: MENS 2
— DERM 3
■ METRIC PARITY
LAST: $1.87 (-0.53%) • MKT CAP: $142.9M
valuation
—
LAST: $4.79 (-7.35%) • MKT CAP: $145.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MENS VS. DERM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MENS | DERM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 65.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.80% | -19.50% | -9.30 | DERM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.13% | -8.15% | +6.02 | MENS | /fcf-yield <GO> |
| Operating Margin | — | -13.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -18.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 11.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.74 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 5/9 | -4.00 | DERM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 40.5 | +5.20 | MENS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $142.9M | $145.9M | -$3.0M | DERM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MENS REV | DERM REV | MENS GROSS % | DERM GROSS % | MENS FCF | DERM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.3M | $61.2M | — | 65.8% | -$3.0M | -$12.4M |
| FY 2024 | $5.8M | $55.1M | — | 62.1% | -$3.6M | -$9.1M |
| FY 2023 | $7.8M | $59.7M | — | — | -$2.6M | $5.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MENS // BETA —
DERM // BETA —